|
1 Company |
|
2 Products |
|
2 Products |
|
6 Mechanisms of Action |
|
0 Trials |
|
5 News |
|
- | NN1213 / Novo Nordisk
Trial completion: Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis (clinicaltrials.gov) - Oct 23, 2018
P4, N=24, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Active, not recruiting --> Completed
- | Enrollment closed, Trial primary completion date: Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis (clinicaltrials.gov) - May 16, 2017
P4, N=20, Active, not recruiting, Sponsor: Dartmouth-Hitchcock Medical Center
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting | Trial primary completion date: Apr 2017 --> Jul 2017
- | New P4 trial: Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis (clinicaltrials.gov) - Apr 7, 2015
P4, N=20, Not yet recruiting, Sponsor: Dartmouth-Hitchcock Medical Center
- New P1 trial: Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Actinic Cheilitis (clinicaltrials.gov) - Jul 23, 2014
P1, N=33, Completed, Sponsor: Dong-A University